These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 17484887)

  • 1. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.
    Imai Y; Varela GM; Jackson MB; Graham MJ; Crooke RM; Ahima RS
    Gastroenterology; 2007 May; 132(5):1947-54. PubMed ID: 17484887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein.
    Liu F; Wang C; Zhang L; Xu Y; Jang L; Gu Y; Cao X; Zhao X; Ye J; Li Q
    Int J Mol Med; 2014 Jan; 33(1):51-8. PubMed ID: 24253218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of adipose differentiation related protein upregulates hepatic VLDL secretion, relieves hepatosteatosis, and improves whole body insulin resistance in leptin-deficient mice.
    Chang BH; Li L; Saha P; Chan L
    J Lipid Res; 2010 Aug; 51(8):2132-42. PubMed ID: 20424269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice.
    Carr RM; Patel RT; Rao V; Dhir R; Graham MJ; Crooke RM; Ahima RS
    Am J Physiol Regul Integr Comp Physiol; 2012 Apr; 302(8):R996-1003. PubMed ID: 22378776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
    Takahashi N; Qi Y; Patel HR; Ahima RS
    J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of farnesoid X receptor (FXR) protects against fructose-induced liver steatosis via inflammatory inhibition and ADRP reduction.
    Liu X; Xue R; Ji L; Zhang X; Wu J; Gu J; Zhou M; Chen S
    Biochem Biophys Res Commun; 2014 Jul; 450(1):117-23. PubMed ID: 24875360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ADRP prevents diet-induced insulin resistance.
    Varela GM; Antwi DA; Dhir R; Yin X; Singhal NS; Graham MJ; Crooke RM; Ahima RS
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G621-8. PubMed ID: 18669627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression.
    Imai Y; Boyle S; Varela GM; Caron E; Yin X; Dhir R; Dhir R; Graham MJ; Ahima RS
    Physiol Genomics; 2012 Nov; 44(22):1125-31. PubMed ID: 23012396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.
    Schadinger SE; Bucher NL; Schreiber BM; Farmer SR
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1195-205. PubMed ID: 15644454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
    Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
    Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet.
    Motomura W; Inoue M; Ohtake T; Takahashi N; Nagamine M; Tanno S; Kohgo Y; Okumura T
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1111-8. PubMed ID: 16403437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
    Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
    Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
    Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
    FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
    Ding X; Saxena NK; Lin S; Gupta NA; Anania FA
    Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bile acid sequestration on hepatic steatosis in obese mice.
    Solís N; Pizarro M; Quintero P; Arab JP; Riquelme A; Padilla O; Carrasco G; Pirola CJ; Sookoian S; Arrese M
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):105-12. PubMed ID: 24378273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.